Showing results (11-20 of 3,907) with videos related to
Sort By:
Pageof 391
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1988
Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shockH Bitterman, A M LeferThe Journal of Antimicrobial Chemotherapy|December 1, 1988
Single low-dose ofloxacin for the treatment of uncomplicated urinary tract infection in young womenR Raz, J Genesin, E Gonen, et al.The Journal of Infection|January 1, 1991
An outbreak of Shigella sonnei infection due to contamination of a municipal water supply in northern IsraelN Egoz, M Shmilovitz, B Kretzer, et al.International Journal of Epidemiology|June 1, 1984
Campylobacter jejuni infections in Haifa subdistrict, Israel, summer 1981S Rishpon, L M Epstein, M Shmilovitz, et al.Shock (Augusta, Ga.)|January 9, 1998
The effect of nitric oxide synthase inhibition on hypertonic saline treatment of controlled hemorrhagic shockM M Krausz, T Amstislavsky, H BittermanProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1988
Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shockH Bitterman, N Aoki, A M LeferCirculatory Shock|January 1, 1987
Use of hypertonic saline in the treatment of hemorrhagic shockH Bitterman, J Triolo, A M LeferCirculatory Shock|January 1, 1986
Beneficial actions of thromboxane receptor antagonism in hemorrhagic shockH Bitterman, A Yanagisawa, A M LeferLymphokine and Cytokine Research|October 1, 1992
Ex vivo secretion of tumor necrosis factor and interleukin-2 by rat splenocytes after intestinal ischemia and shockS Cohen, N Lahat, A Kinarty, et al.Arzneimittel-Forschung|October 1, 1988
Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shockH Bitterman, B A Smith, A M LeferPageof 391